PubRank

Nanhai Chen

Author PubWeight™ 26.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus. Cancer Res 2007 2.69
2 Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virus. Surgery 2007 1.54
3 Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68. Mol Cancer Ther 2009 1.54
4 Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma. Hum Gene Ther 2008 1.53
5 Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo. J Clin Endocrinol Metab 2008 1.35
6 Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68. J Biomed Biotechnol 2010 1.35
7 Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy. BMC Genomics 2009 1.34
8 The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation. Mol Genet Genomics 2009 1.20
9 Anti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapy. Proc Natl Acad Sci U S A 2009 1.19
10 Oncolytic vaccinia therapy of squamous cell carcinoma. Mol Cancer 2009 1.17
11 Genomic sequence and analysis of a vaccinia virus isolate from a patient with a smallpox vaccine-related complication. Virol J 2006 1.15
12 Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3. Vaccine 2007 1.11
13 Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene. Clin Cancer Res 2009 1.10
14 Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68. J Oncol 2010 1.09
15 Real-time intraoperative detection of melanoma lymph node metastases using recombinant vaccinia virus GLV-1h68 in an immunocompetent animal model. Int J Cancer 2009 1.04
16 Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection. J Virol 2007 0.97
17 Effective oncolytic vaccinia therapy for human sarcomas. J Surg Res 2011 0.92
18 A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers. Ann Surg Oncol 2012 0.84
19 The unique C termini of orthopoxvirus gamma interferon binding proteins are essential for ligand binding. J Virol 2006 0.83
20 Biosynthesis of the IFN-gamma binding protein of ectromelia virus, the causative agent of mousepox. Virology 2005 0.81
21 Primary naive and interleukin-2-activated natural killer cells do not support efficient ectromelia virus replication. J Gen Virol 2008 0.81
22 Ectromelia virus inhibitor of complement enzymes protects intracellular mature virus and infected cells from mouse complement. J Virol 2010 0.80
23 Viral binding proteins as antibody surrogates in immunoassays of cytokines. Biotechniques 2002 0.76